Funded by the Swedish Research Council (no. 7461, 5898, 21027, and 342-2004-4434), the Swedish Cancer Foundation, the Knut and Alice Wallenberg Foundation (KAW2007.0118), IngaBritt and Arne Lundberg Foundation, Sahlgren's University Hospital (LUA-ALF), EU-FP7 IBDase, Wilhelm and Martina Lundgren's Foundation, Söderbergs Stiftelser, the Swedish Foundation for Strategic Research – Innate Immunity, and the Mucosal Immunobiology and Vaccine Center (MIVAC), and by a collaborative project grant from AstraZeneca Mölndal, Sweden to the University of Gothenburg.
Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation†
Version of Record online: 2 FEB 2011
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 17, Issue 11, pages 2299–2307, November 2011
How to Cite
Larsson, J. M. H., Karlsson, H., Crespo, J. G., Johansson, M. E.V., Eklund, L., Sjövall, H. and Hansson, G. C. (2011), Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm Bowel Dis, 17: 2299–2307. doi: 10.1002/ibd.21625
- Issue online: 10 OCT 2011
- Version of Record online: 2 FEB 2011
- Manuscript Accepted: 6 DEC 2010
- Manuscript Received: 11 NOV 2010
Additional supporting information may be found in the online version of this article.
|IBD_21625_sm_SuppTables.xls||271K||Supporting Information Tables.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.